Abstracts tagged "Antiphospholipid antibodies and systemic lupus erythematosus (SLE)"

Abstract Number: 2629 • 2018 ACR/ARHP Annual Meeting
Longitudinal Analysis of Persistent Positivity of Antiphospholipid Antibodies in Systemic Lupus Erythematosus
Michelle Petri¹, Mertcan Avci² and Laurence S Magder³, ¹Medicine (Rheumatology), Johns Hopkins University School of Medicine, Baltimore, MD, ²Medicine, Istanbul Faculty of Medicine, Istanbul, Turkey, ³Epidemiology and Preventive Medicine, University of MD, Baltimore, MD
Background/Purpose: ‘Persistent positivity” has been a part of laboratory criteria for antiphospholipid syndrome classification criteria and requires two positive tests. We investigated the clinical utility…
Abstract Number: 703 • 2017 ACR/ARHP Annual Meeting
Clinical Value of Autoantibodies for Lupus Myelitis and Its Subtypes: A Systematic Review
Hiroshi Oiwa¹, Akira Kuriyama², Tomoyasu Matsubara³ and Eiji Sugiyama⁴, ¹Rheumatology, Hiroshima City Hiroshima Citizens Hospital, Hiroshima, Japan, ²General Medicine, Kurashiki Central Hospital, Kurashiki, Japan, ³Neurology, Hiroshima University Hospital, Hiroshima, Japan, ⁴Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan
Background/Purpose: We conducted a systematic review to investigate the clinical value of clinical characteristics and autoantibodies, especially lupus-specific antibodies, for lupus myelitis and its subtypes.…
Abstract Number: 2202 • 2015 ACR/ARHP Annual Meeting
Different Patterns of Positivity for IgG Anti-Cardiolipin, Anti-Beta-2-Glycoprotein I and Anti-Domain I Antibodies within the First Year of Disease in 501 Patients with SLE – Associations with Different Clinical Outcomes
Amrita D'Souza¹, Charis Pericleous², Oliver Leach¹, Karim Fouad Alber¹, Thomas McDonnell², Yiannis Ioannou², Ian Giles³, David A. Isenberg⁴ and Anisur Rahman⁵, ¹Centre for Rheumatology Research, University College London, London, United Kingdom, ²Rayne Institute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ³Rayne Intitiute, Centre for Rheumatology Research, UCL Division of Medicine, London, United Kingdom, ⁴Centre for Rheumatology Research, Rayne Building, 4th Floor, Centre for Rheumatology, Department of Medicine, University College London, London, United Kingdom, ⁵Centre for Rheumatology Research,Rayne Institute, 4th Floor, University College London, London, United Kingdom
Background/Purpose: Antiphospholipid Syndrome (APS) is an autoimmune rheumatic disorder in which antiphospholipid antibodies (aPL) cause clinical sequelae including vascular events (VE) and pregnancy morbidity (PM).…
Abstract Number: 2188 • 2015 ACR/ARHP Annual Meeting
Antiphospholipid Antibodies and the Risk of Damage Accrual in Systemic Lupus Erythematosus
Mara Taraborelli¹, Laura Leuenberger², Maria Grazia Lazzaroni³, Nicole Martinazzi³, Wei Zhang⁴, Jane E. Salmon², Franco Franceschini¹, Angela Tincani³ and Doruk Erkan², ¹Rheumatology and Clinical Immunology, Spedali Civili of Brescia, Brescia, Italy, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, ⁴Healthcare Research Institute, Hospital for Special Surgery, New York, NY
Background/Purpose: A limited number of studies evaluated the impact of antiphospholipid antibodies (aPL) on organ damage in Systemic Lupus Erythematosus (SLE) with contrasting conclusions. The…
Abstract Number: 18 • 2014 ACR/ARHP Annual Meeting
The Effect of Clinically Significant Antiphospholipid Antibody Positivity on Organ Damage in Systemic Lupus Erythematosus
Mara Taraborelli¹, Laura Leuenberger², Wei Zhang³, Angela Tincani¹, Jane Salmon² and Doruk Erkan², ¹Rheumatology and Clinical Immunology, Spedali Civili and University of Brescia, Brescia, Italy, ²Rheumatology, Hospital for Special Surgery, New York, NY, ³Healthcare Research Institute, Hospital for Special Surgery, New York, NY
Background/Purpose: The effect of antiphospholipid antibodies (aPL) on organ damage in Systemic Lupus Erythematosus (SLE) patients remains unclear as there are limited number of studies…
Abstract Number: 3 • 2014 ACR/ARHP Annual Meeting
Is There an Association Between Persistently High Positive Antiphospholipid Antibody Profile and Organ Damage Accrual in Lupus Patients?
Doruk Erkan¹, Lisa G. Criscione-Schreiber², Maria Dall'era³, Olga Dvorkina⁴, Russell Griffin⁵, Galina Marder⁶, Maureen A. McMahon⁷, Jorge Sanchez-Guerrero⁸, Amit Saxena⁹ and Robert Roubey¹⁰, ¹Rheumatology, Hospital for Special Surgery, New York, NY, ²Dept of Med/Rheum Div, Duke University School of Medicine, Durham, NC, ³Medicine/Rheumatology, University of California, San Francisco, San Francisco, CA, ⁴Medicine, SUNY Health Science Center at Brooklyn, Brooklyn, NY, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Medicine, North Shore Long Island Health System, Great Neck, NY, ⁷Division of Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, ⁸UHN Toronto Western Hospital, Toronto, ON, Canada, ⁹Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, ¹⁰Division of Rheumatology and Thurston Arthritis Research Center, University of North Carolina at Chapel Hill, Chapel Hill, NC
Background/Purpose: Few studies assessed the impact of antiphospholipid antibodies (aPL) on organ damage in lupus with conflicting results. Our objective was to determine if persistently…